SCHEMBL8092716

SCHEMBL8092716

CCCCOc1nc(-c2ccc(OC)c(F)c2)c(-c2ccc(S(N)(=O)=O)cc2)cc1C#N

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 18/20 0.51
PTGS1 P23219 15/20 0.51
CDK2 P24941 1/20 0.42
CNR1 P21554 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8094412 0.92 PTGS2 (0.55) PTGS2PTGS1CNR1
SCHEMBL8092693 0.90 PTGS2 (0.50) PTGS2PTGS1CNR1
SCHEMBL8086517 0.89 PTGS2 (0.58) PTGS2PTGS1CDK2
SCHEMBL8094547 0.87 PTGS2 (0.60) PTGS2PTGS1CNR1
SCHEMBL8095044 0.86 PTGS2 (0.64) PTGS2PTGS1
SCHEMBL8093993 0.85 CNR1 (0.47) PTGS2PTGS1CDK2CNR1
SCHEMBL8095632 0.84 PTGS2 (0.56) PTGS2PTGS1CNR1
SCHEMBL8087099 0.84 PTGS2 (0.48) PTGS2PTGS1CNR1
SCHEMBL8092530 0.84 PTGS2 (0.55) PTGS2PTGS1CNR1
SCHEMBL8095681 0.83 CA2 (0.51) PTGS2PTGS1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP claimed
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed